Long Focus Capital Management’s NextCure NXTC Stock Holding History

Long Focus Capital Management’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15,495	Closed	-$143K	–	107
2024 Q4	$143K	Sell	15,495 -30,847	-67%	-$454K	﹤0.01%	100
2024 Q3	$762K	Hold	46,342	–	–	0.03%	90
2024 Q2	$884K	Hold	46,342	–	–	0.03%	87
2024 Q1	$1.24M	Hold	46,342	–	–	0.06%	77
2023 Q4	$634K	Hold	46,342	–	–	0.02%	98
2023 Q3	$717K	Hold	46,342	–	–	0.03%	91
2023 Q2	$1M	Hold	46,342	–	–	0.05%	85
2023 Q1	$823K	Hold	46,342	–	–	0.05%	90
2022 Q4	$784K	Hold	46,342	–	–	0.05%	85
2022 Q3	$1.53M	Hold	46,342	–	–	0.15%	62
2022 Q2	$2.61M	Buy	46,342 +17,175	+59%	+$897K	0.27%	58
2022 Q1	$1.7M	Buy	29,167 +10,417	+56%	+$652K	0.22%	65
2021 Q4	$1.35M	Buy	+18,750	New	+$1.57M	0.18%	64

Other funds holding NXTC

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Long Focus Capital Management's NXTC Position: Q1 2025 in Review

Long Focus Capital Management sold out of NextCure (NXTC) in Q1 2025, closing a stake of 15,495 shares — an estimated $143K sold.

Long Focus Capital Management first reported a position in NXTC in Q4 2021 and held it in 13 quarters. The position peaked at $2.61M in Q2 2022. 38 funds tracked by Wall St. Rank hold NXTC as of Q1 2025.

Long Focus Capital Management reported no remaining NextCure position as of Q1 2025 after selling out during the quarter.
Long Focus Capital Management sold 15,495 NextCure shares in Q1 2025, an estimated $143K.
Long Focus Capital Management first reported a position in NextCure in Q4 2021 and held it in 13 quarters.
Long Focus Capital Management's NextCure position peaked at $2.61M in Q2 2022.
38 funds tracked by Wall St. Rank held NextCure as of Q1 2025.

Based on Long Focus Capital Management's 13F filing for Q1 2025, filed 15 May 2025.